ESC-Leitlinien 2023 zum Management der Endokarditis: Was ist neu?

Suzanne de Waha; Steffen Desch; Roland Tilz; Julia Vogler; Madlen Uhlemann; Mateo Marín-Cuartas; Matthias Raschpichler; Michael Borger

doi:10.1007/s00059-023-05225-y

ESC-Leitlinien 2023 zum Management der Endokarditis: Was ist neu?

Suzanne de Waha^*, Steffen Desch, Roland Tilz, Julia Vogler, Madlen Uhlemann, Mateo Marín-Cuartas, Matthias Raschpichler, Michael Borger

^*Korrespondierende/r Autor/-in für diese Arbeit

Universität Leipzig

1 Zitat (Scopus)

Abstract

In August 2023 the new European guidelines on the management of infective endocarditis were published by the European Society of Cardiology (ESC). Numerous recommendations were revised and supplemented by new ones. This review article outlines the essential modifications of the current ESC guidelines focusing on the prevention including antibiotic prophylaxis, the role of the endocarditis team, the revision of the diagnostic criteria, the paradigm shift towards oral antibiotic treatment, the timing and the indications for surgical treatment as well as the relevance of infections of cardiovascular implantable electronic devices.

Titel in Übersetzung	ESC guidelines 2023 on the management of endocarditis: What is new?
Originalsprache	Deutsch
Zeitschrift	Herz
Jahrgang	49
Ausgabenummer	1
Seiten (von - bis)	33-42
Seitenumfang	10
ISSN	0340-9937
DOIs	https://doi.org/10.1007/s00059-023-05225-y
Publikationsstatus	Veröffentlicht - 02.2024

Strategische Forschungsbereiche und Zentren

Zentren: Universitäres Herzzentrum Lübeck (UHZL)

DFG-Fachsystematik

2.22-12 Kardiologie, Angiologie

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

Dokumente

10.1007/s00059-023-05225-y

Weitere Links

Zitieren

@article{db1845db8835493f80ce42e22da0dce5,

title = "ESC-Leitlinien 2023 zum Management der Endokarditis: Was ist neu?",

abstract = "In August 2023 the new European guidelines on the management of infective endocarditis were published by the European Society of Cardiology (ESC). Numerous recommendations were revised and supplemented by new ones. This review article outlines the essential modifications of the current ESC guidelines focusing on the prevention including antibiotic prophylaxis, the role of the endocarditis team, the revision of the diagnostic criteria, the paradigm shift towards oral antibiotic treatment, the timing and the indications for surgical treatment as well as the relevance of infections of cardiovascular implantable electronic devices.",

author = "{de Waha}, Suzanne and Steffen Desch and Roland Tilz and Julia Vogler and Madlen Uhlemann and Mateo Mar{\'i}n-Cuartas and Matthias Raschpichler and Michael Borger",

note = "Publisher Copyright: {\textcopyright} 2023, The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.",

year = "2024",

month = feb,

doi = "10.1007/s00059-023-05225-y",

language = "Deutsch",

volume = "49",

pages = "33--42",

journal = "Herz",

issn = "0340-9937",

number = "1",

}

TY - JOUR

T1 - ESC-Leitlinien 2023 zum Management der Endokarditis

T2 - Was ist neu?

AU - de Waha, Suzanne

AU - Desch, Steffen

AU - Tilz, Roland

AU - Vogler, Julia

AU - Uhlemann, Madlen

AU - Marín-Cuartas, Mateo

AU - Raschpichler, Matthias

AU - Borger, Michael

PY - 2024/2

Y1 - 2024/2

N2 - In August 2023 the new European guidelines on the management of infective endocarditis were published by the European Society of Cardiology (ESC). Numerous recommendations were revised and supplemented by new ones. This review article outlines the essential modifications of the current ESC guidelines focusing on the prevention including antibiotic prophylaxis, the role of the endocarditis team, the revision of the diagnostic criteria, the paradigm shift towards oral antibiotic treatment, the timing and the indications for surgical treatment as well as the relevance of infections of cardiovascular implantable electronic devices.

AB - In August 2023 the new European guidelines on the management of infective endocarditis were published by the European Society of Cardiology (ESC). Numerous recommendations were revised and supplemented by new ones. This review article outlines the essential modifications of the current ESC guidelines focusing on the prevention including antibiotic prophylaxis, the role of the endocarditis team, the revision of the diagnostic criteria, the paradigm shift towards oral antibiotic treatment, the timing and the indications for surgical treatment as well as the relevance of infections of cardiovascular implantable electronic devices.

UR - http://www.scopus.com/inward/record.url?scp=85179687620&partnerID=8YFLogxK

UR - https://www.mendeley.com/catalogue/da456190-1d0e-3d2c-8589-ce683ff1dcbe/

U2 - 10.1007/s00059-023-05225-y

DO - 10.1007/s00059-023-05225-y

M3 - Übersichtsarbeiten

C2 - 38092975

AN - SCOPUS:85179687620

SN - 0340-9937

VL - 49

SP - 33

EP - 42

JO - Herz

JF - Herz

IS - 1

ER -

ESC-Leitlinien 2023 zum Management der Endokarditis: Was ist neu?

Abstract

Strategische Forschungsbereiche und Zentren

DFG-Fachsystematik

UN SDGs

Dokumente

Weitere Links

Fingerprint

Zitieren